Major depressive disorder clinical trials

What Is Pediatric Atopic Dermatitis?

Pediatric atopic dermatitis is a chronic inflammatory skin condition that commonly begins during infancy or early childhood. It causes dry, itchy, and inflamed skin, with symptoms that often come and go over time. While many children experience mild flare-ups, others may develop more persistent symptoms that affect sleep, daily activities, and overall quality of life. Early diagnosis and appropriate management can help reduce flare-ups and improve long-term skin health.

Pediatric clinical trials are ongoing to evaluate potential new treatment options that may help improve symptom control and quality of life for children living with atopic dermatitis.

Enroll Now!

STUDY

Evaluating New Possibilities in Pediatric Atopic Dermatitis Care

Clinical research plays an important role in advancing potential new treatment options through carefully designed studies. This child eczema research study in Colorado is evaluating the safety and effectiveness of an investigational cream in children between 3 and 23 months of age. The research aims to learn more about this investigational treatment and contribute to the development of future treatment options for children living with eczema.

Participation in this pediatric atopic dermatitis clinical trials may give eligible children access to an investigational treatment and includes close medical monitoring from the study team. It also helps advance research that may contribute to better treatment approaches for young children living with atopic dermatitis.

Age
3 Months to 23 Months (Child)

Location:
All

Status:
Recruiting

Condition
Atopic Dermatitis

What to Expect During the Pediatric Atopic Dermatitis Clinical Trials

In this child eczema clinical study, participants can expect a carefully designed and closely monitored research process. After screening to confirm eligibility, eligible children will receive study-related care according to the study protocol. Throughout the trial, participants will attend scheduled visits where researchers will evaluate their safety, response to the study treatment, and overall health.

Parents or caregivers will share updates about their child’s skin condition and any changes observed throughout the study period. The research team will closely monitor participants throughout the trial to help evaluate the investigational treatment and contribute to research on potential future treatment options for pediatric atopic dermatitis.

Frequently Asked
Questions

  • This pediatric atopic dermatitis clinical trial is designed to evaluate the safety and effectiveness of an investigational cream in children between 3 months and 23 months of age with atopic dermatitis. The study helps researchers better understand how the investigational treatment performs in young children.

  • Children between 3 months and 23 months of age who have atopic dermatitis may be eligible to participate. A screening process will be conducted by the study team to determine if a child meets the requirements for enrollment.

  • During the study, participants will attend scheduled visits where researchers will monitor safety, evaluate treatment response, and assess overall health. Parents or caregivers will provide updates about their child’s condition and any changes observed throughout the trial.